Body weight management and safety with efpeglenatide in adults without diabetes: a phase II randomized study

Richard E. Pratley,Jahoon Kang,Michael E. Trautmann,Marcus Hompesch,Oakpil Han,John Stewart,Christopher H. Sorli,S. Jacob,Kun-Ho Yoon

Body weight management and safety with efpeglenatide in adults without diabetes: a phase II randomized study

2019

Richard E. Pratley
Jahoon Kang
Michael E. Trautmann
Marcus Hompesch
Oakpil Han
John Stewart
Christopher H. Sorli
S. Jacob
Kun-Ho Yoon

Aim To evaluate the safety of efpeglenatide, a long‐acting glucagon‐like peptide‐1 receptor agonist (GLP‐1RA), and its effects on body weight management in adults without diabetes.

Keywords:

Endocrinology
Pediatrics
Internal medicine
Randomized controlled trial
Body weight
Diabetes mellitus
Medicine
Gastroenterology
Repeated measures design
Placebo
Weight management
Adverse effect
Clinical endpoint
Body mass index

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations